Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,049
Closed -$1.26M 24
2025
Q4
$1.26M Buy
+10,049
New +$1.28M 1.26% 19
2023
Q1
Sell
-8,909
Closed -$978K 24
2022
Q4
$978K Buy
8,909
+188
+2% +$19.5K 0.78% 25
2022
Q3
$844K Sell
8,721
-200
-2% -$21.3K 0.73% 25
2022
Q2
$969K Sell
8,921
-727
-8% -$82.6K 0.77% 24
2022
Q1
$1.19M Sell
9,648
-10
-0.1% -$1.24K 0.83% 25
2021
Q4
$1.19M Hold
9,658
1.02% 23
2021
Q3
$1.14M Buy
9,658
+573
+6% +$70.4K 0.87% 26
2021
Q2
$1.05M Sell
9,085
-256
-3% -$29.8K 0.7% 26
2021
Q1
$1.12M Buy
9,341
+21
+0.2% +$2.49K 0.79% 28
2020
Q4
$1.02M Sell
9,320
-675
-7% -$73.4K 0.8% 27
2020
Q3
$1.09M Buy
+9,995
New +$1.01M 1.04% 23

Other funds holding ABT

XXEC Inc's ABT Position: Q1 2026 in Review

XXEC Inc sold out of Abbott (ABT) in Q1 2026, closing a stake of 10,049 shares — an estimated $1.26M sold.

XXEC Inc first reported a position in ABT in Q3 2020 and held it in 11 quarters. The position peaked at $1.26M in Q4 2025. 3,090 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • XXEC Inc reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • XXEC Inc sold 10,049 Abbott shares in Q1 2026, an estimated $1.26M.
  • XXEC Inc first reported a position in Abbott in Q3 2020 and held it in 11 quarters.
  • XXEC Inc's Abbott position peaked at $1.26M in Q4 2025.
  • 3,090 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on XXEC Inc's 13F filing for Q1 2026, filed 24 Apr 2026.